Michael Kolovetsios

Johnson & Johnson MedTech

Michael Kolovetsios is listed at Johnson & Johnson MedTech. Michael spoke at ISPOR Europe 2026 in November 2026 (speaker, “Beyond the Trial: Real-World Evidence and Lifecycle Evidence Generation in NICE Existing-Use HealthTech Assessments”). Speaks mainly at Government Administration events.

Compiled from published conference agendas; not yet confirmed by Michael. Is this you? Claim this profile.

• Sector: Government Administration

Sessions at 1 conference

ISPOR Europe 2026 8 November 2026 – 11 November 2026

• Beyond the Trial: Real-World Evidence and Lifecycle Evidence Generation in NICE Existing-Use HealthTech Assessments Speaker · 10 November 2026

Spoke alongside

People who have shared a session with Michael at events on B2DB.

• Anastasia Chalkidou NICE 1 shared session
• Dawn Lee University of Exeter PenTAG 1 shared session
• Stacey Chang-Douglass Clarivate 1 shared session